TCL Archive Carcinogenesis Testing Moved Out of DCCP To New Status As Division, Giving Rall More Authority September 14, 1979
TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive In Brief: NCI Holds Paylines To 160, 165 for Now While Anticipating Another OMB Rescission Request November 14, 1986
TCL Archive In Brief: Kripke, Fidler To Leave FCRF for M.D. Anderson; George Todaro Takes Job With New Seattle Firm March 4, 1983
TCL Archive FDA cancer therapeutics review split among three units in reorganization. October 10, 2003
